Table 2.
Baseline demographic and clinical characteristics of Barth syndrome patients enrolled in the TAZPOWER Trial [16]
| Characteristic | Value |
|---|---|
| Mean age, y (range) | 19.5 (12–35) |
| Male, n (%) | 12 (100) |
| Race, n (%) | |
| White | 11 () |
| Multiracial | 1 () |
| Ethnicity, n (%) | |
| Not Hispanic or Latino | 12 (100) |
| Hispanic or Latino | 0 |
| Mean height, cm (range) | 167.3 (150.4–187.7) |
| Mean weight, kg (range) | 50.8 (31.4–85.9) |
| BMI, kg/m2 (range) | 17.6 (13.6–24.4) |
| 6MWT, m | 395.5 |
| Mean BTHS-SA total fatigue score | 8 |
| Mean 3D LVEDV, Z-score (SD) | –2 (1.34) |
| Mean 3D LVSV, Z-score (SD) | –1.84 (1.53) |
| Mean EF, % (SD) | 60.6 (4.0) |
Used with permission from [Thompson et al. 16]
6MWT 6-min walk test, BTHS-SA Barth Syndrome Symptom Assessment scale, BMI body-mass index, EF ejection fraction, LVEDV left ventricular end-diastolic volume, LVSV left ventricular stroke volume, SD standard deviation, y year